相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。B Cells and Tertiary Lymphoid Structures: Friends or Foes in Cancer Immunotherapy?
Martin Lauss et al.
CLINICAL CANCER RESEARCH (2022)
Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing cells in renal cell cancer
Maxime Meylan et al.
IMMUNITY (2022)
Epigenetic Therapies in Ovarian Cancer Alter Repetitive Element Expression in a TP53-Dependent Manner
James McDonald et al.
CANCER RESEARCH (2021)
Immunotherapy in ovarian cancer: we are not there yet
Emma Barber et al.
LANCET ONCOLOGY (2021)
Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study
Eric Pujade-Lauraine et al.
LANCET ONCOLOGY (2021)
Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer
Lawrence Fong et al.
CANCER DISCOVERY (2020)
A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer
Amit M. Oza et al.
CLINICAL CANCER RESEARCH (2020)
B cells are associated with survival and immunotherapy response in sarcoma
Florent Petitprez et al.
NATURE (2020)
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
Rita Cabrita et al.
NATURE (2020)
B cells and tertiary lymphoid structures promote immunotherapy response
Beth A. Helmink et al.
NATURE (2020)
CD4+ T-cell Immunity in the Peripheral Blood Correlates with Response to Anti-PD-1 Therapy
Hiroshi Kagamu et al.
CANCER IMMUNOLOGY RESEARCH (2020)
OX40+ plasmacytoid dendritic cells in the tumor microenvironment promote antitumor immunity
Kate Poropatich et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
LAG3 (LAG-3, CD223) DNA methylation correlates with LAG3 expression by tumor and immune cells, immune cell infiltration, and overall survival in clear cell renal cell carcinoma
Niklas Kluemper et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors
Kurt A. Schalper et al.
NATURE MEDICINE (2020)
High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade
Kobe C. Yuen et al.
NATURE MEDICINE (2020)
Serum interleukin-6 and C-reactive protein are associated with survival in melanoma patients receiving immune checkpoint inhibition
Andressa S. Laino et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer Phase 1b Results From the JAVELIN Solid Tumor Trial
Mary L. Disis et al.
JAMA ONCOLOGY (2019)
Functional systemic CD4 immunity is required for clinical responses to PD-L1/PD-1 blockade therapy
Miren Zuazo et al.
EMBO MOLECULAR MEDICINE (2019)
Telescope: Characterization of the retrotranscriptome by accurate estimation of transposable element expression
Matthew L. Bendall et al.
PLOS COMPUTATIONAL BIOLOGY (2019)
On the Role of Adenosine A2A Receptor Gene Transcriptional Regulation in Parkinson's Disease
Anastasia Falconi et al.
FRONTIERS IN NEUROSCIENCE (2019)
The Role of Tumor-Infiltrating B Cells in Tumor Immunity
Fei Fei Guo et al.
JOURNAL OF ONCOLOGY (2019)
Pembrolizumab in patients with programmed death ligand 1-positive advanced ovarian cancer: Analysis of KEYNOTE-028
Andrea Varga et al.
GYNECOLOGIC ONCOLOGY (2019)
Clinical response to PD-1 blockade correlates with a sub-fraction of peripheral central memory CD4(+) T cells in patients with malignant melanoma
Yoshiko Takeuchi et al.
INTERNATIONAL IMMUNOLOGY (2018)
Combined Blockade of IL6 and PD-1/PD-L1 Signaling Abrogates Mutual Regulation of Their Immunosuppressive Effects in the Tumor Microenvironment
Hirotake Tsukamoto et al.
CANCER RESEARCH (2018)
A Phase I Clinical Trial of Guadecitabine and Carboplatin in Platinum-Resistant, Recurrent Ovarian Cancer: Clinical, Pharmacokinetic, and Pharmacodynamic Analyses
Daniela Matei et al.
CLINICAL CANCER RESEARCH (2018)
High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy (vol 24, pg 144, 2018)
Carsten Krieg et al.
NATURE MEDICINE (2018)
A2AR Antagonism with CPI-444 Induces Antitumor Responses and Augments Efficacy to Anti-PD-(L)1 and Anti-CTLA-4 in Preclinical Models
Stephen B. Willingham et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Genomic and Epigenomic Signatures in Ovarian Cancer Associated with Resensitization to Platinum Drugs
Fang Fang et al.
CANCER RESEARCH (2018)
Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial
Hagop M. Kantarjian et al.
LANCET ONCOLOGY (2017)
Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden
Meredith L. Stone et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Promoter Methylation Modulates Indoleamine 2,3-Dioxygenase 1 Induction by Activated T Cells in Human Breast Cancers
Satish K. Noonepalle et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade
Spencer C. Wei et al.
CELL (2017)
Combining Epigenetic and Immunotherapy to Combat Cancer
Katherine B. Chiappinelli et al.
CANCER RESEARCH (2016)
DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts
David Roulois et al.
CELL (2015)
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses
Katherine B. Chiappinelli et al.
CELL (2015)
FlowSOM: Using self-organizing maps for visualization and interpretation of cytometry data
Sofie Van Gassen et al.
CYTOMETRY PART A (2015)
Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study
Jean-Pierre J. Issa et al.
LANCET ONCOLOGY (2015)
Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
Dongjun Peng et al.
NATURE (2015)
Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Edward B. Garon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Adenosine Receptor 2A Blockade Increases the Efficacy of Anti-PD-1 through Enhanced Antitumor T-cell Responses
Paul A. Beavis et al.
CANCER IMMUNOLOGY RESEARCH (2015)
TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells
Horacio Cardenas et al.
EPIGENETICS (2014)
Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents
H. Yang et al.
LEUKEMIA (2014)
Automated identification of stratifying signatures in cellular subpopulations
Robert V. Bruggner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Decitabine reactivated pathways in platinum resistant ovarian cancer
Fang Fang et al.
ONCOTARGET (2014)
Epigenetic Potentiation of NY-ESO-1 Vaccine Therapy in Human Ovarian Cancer
Kunle Odunsi et al.
CANCER IMMUNOLOGY RESEARCH (2014)
viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia
El-ad David Amir et al.
NATURE BIOTECHNOLOGY (2013)
Epigenetic Resensitization to Platinum in Ovarian Cancer
Daniela Matei et al.
CANCER RESEARCH (2012)
An epigenetic mechanism for high, synergistic expression of indoleamine 2,3-dioxygenase 1 (IDO1) by combined treatment with zebularine and IFN-γ: Potential therapeutic use in autoimmune diseases
Zhong-Tian Xue et al.
MOLECULAR IMMUNOLOGY (2012)
Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE
Peng Qiu et al.
NATURE BIOTECHNOLOGY (2011)
Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum
Sean C. Bendall et al.
SCIENCE (2011)
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
Mark D. Robinson et al.
BIOINFORMATICS (2010)
CD73 on Tumor Cells Impairs Antitumor T-Cell Responses: A Novel Mechanism of Tumor-Induced Immune Suppression
Dachuan Jin et al.
CANCER RESEARCH (2010)
Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer
Meng Li et al.
BMC MEDICAL GENOMICS (2009)
Treatment of ovarian cancer cell lines with 5-aza-2'-deoxycytidine upregulates the expression of cancer-testis antigens and class I major histocompatibility complex-encoded molecules
Sara J. Adair et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Intertumor and intratumor NY-ESO-1 expression heterogeneity is associated with promoter-specific and global DNA methylation status in ovarian cancer
Anna Woloszynska-Read et al.
CLINICAL CANCER RESEARCH (2008)
A2A adenosine receptor protects tumors from antitumor T cells
Akio Ohta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
New anti-cancer strategies: Epigenetic therapies and biomarkers
C Balch et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2005)
Analysis of repetitive element DNA methylation by MethyLight
DJ Weisenberger et al.
NUCLEIC ACIDS RESEARCH (2005)
A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements -: art. no. e38
AS Yang et al.
NUCLEIC ACIDS RESEARCH (2004)
The fundamental role of epigenetic events in cancer
PA Jones et al.
NATURE REVIEWS GENETICS (2002)
Significance analysis of microarrays applied to the ionizing radiation response
VG Tusher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
分享论文
